Beacon Pharmaceuticals PLC
102.50
BDT
-3.10
-2.94%
Last updated on 03 Mar, 13:51
Today
-2.94%
1 Week
-5.96%
1 Month
-3.94%
6 Month
-25.29%
1 Year
-18.91%
5 Year
-6.56%
Matket Today
Open
105.7
BDT
Low
102.2
BDT
High
105.7
BDT
Volume
215566
Value
2.23
Crore
Trade
912
YCP
105.6
BDT
52W Low
87.4
BDT
52W High
147.5
BDT
Circuit Low
95.1
BDT
Circuit Up
116.1
BDT
Beta (1 Year)
1.46
Financial Indicators
P/E ratio
10.84
EPS (TTM)
9.46
NAV (Q2 2026)
32.32
Total Shares
23.10
Crore
Shot-term loan
688.43
Crore
Long-term loan
319.31
Crore
Market Capital
2439.36
Crore
Paid-up Capital
231.00
Crore
Authorized Capital
300
Crore
Last AGM Date
23 Dec 2025
Last Record Date
16 Nov 2025
Year End
30-Jun
About Beacon Pharmaceuticals PLC
Sector
Pharmaceuticals & Chemicals
Listing Year
2010
beacon@beaconpharma.com.bd
Established in 2006, Beacon Pharmaceuticals PLC has rapidly grown to become the leading oncology company and one of the fastest-growing pharmaceutical companies in Bangladesh. The company boasts state-of-the-art manufacturing facilities adhering to global standards like US FDA, UK MHRA, TGA Australia, and WHO GMP. Specializing in oncology, biotech, hi-tech, and general pharmaceuticals, Beacon manufactures over 200 world-class generic drugs and has introduced several global first generic drugs. Beyond catering to local demand, Beacon exports its medicines to various countries in Asia, Africa, Europe, and Latin America. The company's focus on oncology, commitment to innovation, and adherence to international quality standards have positioned it as a prominent player in the global pharmaceutical landscape.